ROLE OF MITOCHONDRIAL/METABOLIC REPROGRAMMING IN CONTROLLING ABERRANT GENE EXPRESSION IN PULMONARY HYPERTENSION
$1,866,000FY2020Defense Health AgencyDOD
The Regents Of The University Of Colorado
Investigators
View source on USAspending →ROLE OF MITOCHONDRIAL/METABOLIC REPROGRAMMING IN CONTROLLING ABERRANT GENE EXPRESSION IN PULMONARY HYPERTENSION · GrantIndex